DRL News Today

Dhanuka Realty Ltd Share Price

DRL

CMP as on 06-Mar-24 12:00
₹ 26

icon -1.35 | -4.87%

Open
₹ 26
Turnover(lac)
₹ 6
Prev. Close
₹ 27.70
Day's Vol (shares)
₹ 24,000
Day's Vol (shares)
₹ 26.35         ₹ 26.35

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
Image not found

Dr. Reddy's Labs: Valuations out of sync versus base business fundamentals

Following IIFL’s January 2023 recommendation downgrade on Dr. Reddy’s Labs (Dr. Reddy’s), analysts at IIFL Securities have further cut their rating to Reduce (from Add). The stock’s 15% rally YTD seems to be out of sync with continued muted trends on the base business (ex-Revlimid).

  • 11 May, 2023 |
  • 11:53 AM
Image not found

Q3FY23 Preview: Dr. Reddy's Laboratories: Revenue seen at Rs62,016 million, PAT at Rs9,919 million

Healthy performance likely on a year-on-year basis

  • 24 Jan, 2023 |
  • 12:15 PM
Image not found

LIC boosts its stake in Dr Reddy's Laboratories from 5.65% to 7.7%

According to Dr Reddy's Laboratories Ltd, Life Insurance Corporation of India raised its ownership in the pharmaceutical company by purchasing 33.86 lakh shares, bringing its interest to 7.7%.

  • 04 Oct, 2022 |
  • 8:45 AM
Image not found

Q4FY22 Preview: Dr. Reddy's Laboratories: Revenues seen at Rs50,746 million, PAT at Rs6,253 million

Single digit growth likely in key metrics versus the year-ago quarter

  • 18 May, 2022 |
  • 7:51 AM